What other dual antiplatelet therapy duration trials are being conducted? How is the DAPT Study different from the others?
A number of studies examining optimal duration of dual antiplatelet therapy following drug-eluting stent placement are currently being conducted globally. Some randomized studies are examining the duration of 12 months versus of longer treatment, as is the DAPT Study. Some randomized studies are alternately examining the duration of 12 months versus a shorter treatment. While each of these studies adds complementary information, the DAPT Study is distinguished by its size and scope, and has sufficient power to compare both co-primary endpoints of stent thrombosis and clinical events.
